Search

Displaying results 8291 - 8300 of 10000 in total
  1. Drug

    CTX110

    go.drugbank.com/drugs/DB18626
    Investigational

    CTX110 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD19 antigen.

  2. Drug

    Rivenprost

    go.drugbank.com/drugs/DB16315
    Investigational

    Rivenprost is under investigation in clinical trial NCT00296556 (Therapeutic Study of ONO-4819CD for Ulcerative Colitis).

  3. Drug

    Tanimilast

    go.drugbank.com/drugs/DB12800
    Investigational

    CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease.

  4. Drug

    BK-MDA

    go.drugbank.com/drugs/DB12809
    Investigational

    BK-MDA has been used in trials studying the treatment of Bladder Exstrophy and Urinary Incontinence.

  5. Drug

    Oleandrin

    go.drugbank.com/drugs/DB12843
    Investigational

    Oleandrin has been used in trials studying the treatment of Lung Cancer and Chemotherapeutic Agent Toxicity.

  6. Drug

    Pradigastat

    go.drugbank.com/drugs/DB12866
    Investigational

    Pradigastat has been used in trials studying the treatment of Non-alcoholic Fatty Liver Disease (NAFLD).

  7. Drug

    Namodenoson

    go.drugbank.com/drugs/DB12885
    Investigational

    Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

    Synonyms: 2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide
  8. Drug

    Dimiracetam

    go.drugbank.com/drugs/DB13018
    Investigational

    Dimiracetam has been used in trials studying the treatment of AIDS, Neuropathy, and Acquired Immunodeficiency Syndrome.

  9. Drug

    123I-iodometomidate

    go.drugbank.com/drugs/DB13021
    Investigational

    123I-iodometomidate is under investigation in clinical trial NCT00454103 (Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy).

  10. Drug

    Clorindione

    go.drugbank.com/drugs/DB13275
    Experimental

    Clorindione is a vitamin K antagonist, which may be useful to decrease prothrombin levels in humans.